Video: Albert Pujols moves up on all-time RBI list with home run

Albert Pujols
Getty Images

Albert Pujols continued to build on his Hall of Fame case on Friday after launching a 430-foot home run off of the Royals’ Danny Duffy. The Angels slugger scored David Fletcher to put up a two-spot in the first inning and give the club an early advantage; it was just his fourth home run and 12th and 13th RBI of the season to date.

Adding those to his career totals, Pujols now boasts a cumulative 637 homers and 1,995 runs batted in, the latter of which Elias Sports considers good enough to land him a fourth-place spot on the all-time list behind Hank Aaron (2,297), Álex Rodríguez (2,086), and Barry Bonds (1,996).

After he passes Bonds up, he’ll have a ways to go in order to overtake A-Rod for the no. 3 spot.

The Angels currently lead the Royals 3-0 in the sixth.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.